HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria.

Abstract
We assessed monthly doses of tafenoquine for preventing Plasmodium vivax and multidrug-resistant P. falciparum malaria. In a randomized, double-blind, placebo-controlled study, 205 Thai soldiers received either a loading dose of tafenoquine 400 mg (base) daily for 3 days, followed by single monthly 400-mg doses (n = 104), or placebo (n = 101), for up to 5 consecutive months. In volunteers completing follow-up (96 tafenoquine and 91 placebo recipients), there were 22 P. vivax, 8 P. falciparum, and 1 mixed infection. All infections except 1 P. vivax occurred in placebo recipients, giving tafenoquine a protective efficacy of 97% for all malaria (95% confidence interval [CI], 82%-99%), 96% for P. vivax malaria (95% CI, 76%-99%), and 100% for P. falciparum malaria (95% CI, 60%-100%). Monthly tafenoquine was safe, well tolerated, and highly effective in preventing P. vivax and multidrug-resistant P. falciparum malaria in Thai soldiers during 6 months of prophylaxis.
AuthorsDouglas S Walsh, Chirapa Eamsila, Theerayuth Sasiprapha, Suebpong Sangkharomya, Pradith Khaewsathien, Panpaka Supakalin, Douglas B Tang, Phongsak Jarasrumgsichol, Chainarong Cherdchu, Michael D Edstein, Karl H Rieckmann, Thomas G Brewer
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 190 Issue 8 Pg. 1456-63 (Oct 15 2004) ISSN: 0022-1899 [Print] United States
PMID15378438 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright 2004 Infectious Diseases Society of America
Chemical References
  • Aminoquinolines
  • Antimalarials
  • tafenoquine
Topics
  • Administration, Oral
  • Aminoquinolines (therapeutic use)
  • Animals
  • Antimalarials (therapeutic use)
  • Double-Blind Method
  • Drug Administration Schedule
  • Drug Resistance, Multiple
  • Follow-Up Studies
  • Humans
  • Malaria, Falciparum (prevention & control)
  • Malaria, Vivax (prevention & control)
  • Military Personnel
  • Plasmodium falciparum (drug effects)
  • Thailand
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: